---

title: NSAIDs and Upper GI Bleed
authors:
    - Michelle Lin, MD
created: 2011/07/15
updates:
categories:
    - Gastroenterology
    - Pharmacology
---

# NSAIDs and Upper GI Bleed

- Stomach and platelets have much more COX-1 receptors than COX-2 receptors.
- Below are statistics from a systematic review on NSAIDs and upper GI complications (bleeding, perforation)

## Ketorolac 

- Has the highest relative risk for upper GI complication = 14.54 (see below)
- Before giving, first check that patients do NOT have a history of a GI bleed or peptic ulcer disease.

## NSAID-Induced Complications

| **NSAID Medication**                      | **Estimated Relative Risk of Complication** | **[95 % CI]** |
| ----------------------------------------- | :-----------------------------------------: | :-----------: |
| COX-1 Inhibitors (all)                    |                     4.5                     |   [3.82-5.31] |
|  - <span class="drug">Ibuprofen</span>    |                     2.69                    |  [2.17-3.33]  |
|  - <span class="drug">Diclofenac</span>   |                     3.98                    |  [3.36-4.72]  |
|  - <span class="drug">Meloxicam</span>    |                     4.15                    |  [2.59-6.64]  |
|  - <span class="drug">Indomethacin</span> |                     5.40                    |  [4.16-7.00]  |
|  - <span class="drug">Ketoprofen</span>   |                     5.57                    |  [3.94-7.87]  |
|  - <span class="drug">Naproxen</span>     |                     5.63                    |  [3.83-8.28]  |
|  - <span class="drug">Piroxicam</span>    |                     9.94                    |  [5.99-16.50] |
|  - <span class="drug">Ketorolac</span>    |                    14.54                    |  [5.87-36.04] |
| COX-2 Inhibitors (all)                    |                     1.88                    |  [0.96-3.71]  |
|  - <span class="drug">Celecoxib</span>    |                     1.42                    |  [0.85-2.37]  |
|  - <span class="drug">Aceclofenac</span>  |                     1.44                    |   [0.65-3.2]  |
|  - <span class="drug">Rofecoxib</span>    |                     2.12                    |  [1.59-2.84]  |

## Risk Factors for Upper GI Complication

1. Longer drug half-life
2. Slow-release formulation
3. Dual inhibition of COX-1 and COX-2 isoenzymes 

Relative risk is greatest when first starting medication (&lt;30 days)

## References

- Massó González EL, Patrignani P, Tacconelli S, García Rodríguez LA. Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding. Arthritis Rheum. 2010 Jun;62(6):1592-601 [[PubMed](http://www.ncbi.nlm.nih.gov/pubmed/?term=20178131)]
